The Discovery Labs has signed a foundational lease with the University of Pennsylvania Gene Therapy Program (GTP), which will use Discovery Labs’ suburban campus for a portion of its expanding research operations focused on the  development of genetic medicines for rare and orphan diseases, as well as acquired and pandemic infectious diseases, such as COVID-19.   The lease with Penn’s Gene Therapy Program—led by James M. Wilson, MD, PhD, director, Gene Therapy Program; Rose H. Weiss professor an...